title: Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients.
abstract: OBJECTIVE
  To evaluate the efficacy, amount of hemorrhage, biliary leakage, complications, and postoperative evolution after fibrin glue sealant application in patients undergoing liver resection.
  
  
  BACKGROUND
  Fibrin sealants have become popular as a means of improving perioperative hemostasis and reducing biliary leakage after liver surgery. However, trials regarding its use in liver surgery remain limited and of poor methodologic quality.
  
  
  METHODS
  A total of 300 patients undergoing hepatic resection were randomly assigned to fibrin glue application or control groups. Characteristics and debit of drainage and postoperative complications were evaluated. The amount of blood loss, measurements of hematologic parameters liver test, and postoperative evolution (particularly involving biliary fistula and morbidity) was also recorded.
  
  
  RESULTS
  Postoperatively, no differences were observed in the amount of transfusion (0.15 +/- 0.66 vs. 0.17 +/- 0.63 PRCU; P = 0.7234) or in the patients that required transfusion (18% vs. 12%; P = 0.2), respectively, for the fibrin glue or control group. There were no differences in overall drainage volumes (1180 +/- 2528 vs. 960 +/- 1253 mL) or in days of postoperative drainage (7.9 +/- 5 vs. 7.1 +/- 4.7). Incidence of biliary fistula was similar in the fibrin glue and control groups, (10% vs. 11%). There were no differences regarding postoperative morbidity between groups (23% vs. 23%; P = 1).
  
  
  CONCLUSIONS
  Application of fibrin sealant in the raw surface of the liver does not seem justified. Blood loss, transfusion, incidence of biliary fistula, and outcome are comparable to patients without fibrin glue. Therefore, discontinuation of routine use of fibrin sealant would result in significant cost saving.
authors.affiliation: Departments of Surgery, Hospital de Bellvitge, University of Barcelona, Barcelona, Spain. info@jfigueras.net
authors.forename: Juan
authors.initials: J
authors.lastname: Figueras
authors.forename: Laura
authors.initials: L
authors.lastname: Llado
authors.forename: Mónica
authors.initials: M
authors.lastname: Miro
authors.forename: Emilio
authors.initials: E
authors.lastname: Ramos
authors.forename: Jaume
authors.initials: J
authors.lastname: Torras
authors.forename: Juan
authors.initials: J
authors.lastname: Fabregat
authors.forename: Teresa
authors.initials: T
authors.lastname: Serrano
mesh_terms: D000368:Aged; D016063:Blood Loss, Surgical / Q000517:prevention & control / Q000706:statistics & numerical data; D017046:Cost Savings; D004322:Drainage; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000191:economics / Q000627:therapeutic use*; D006400:Hematocrit; D006498:Hepatectomy / Q000191:economics / Q000379:methods / Q000401:mortality; D006801:Humans; D007902:Length of Stay; D008103:Liver Cirrhosis / Q000601:surgery; D008107:Liver Diseases / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology*; D012307:Risk Factors
chemical_list: D015718:Fibrin Tissue Adhesive